Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday.

Gushika ico gihe, kurongorwa canke kwitwa umuvyeyi vyari nk'indoto za kure kuri Kinjal, kubera yari afise ikibazo gikomeye ca 'beta thalassemia', ingwara yo mu maraso ituma umuntu adashobora kwinjiza ...

Doctors harvest stem cells from the patient’s bone marrow and then send them off to a lab, where CRISPR is used to turn up the production of another, functional version of haemoglobin. This version is ...